Skip to main content

News & Announcements

Rare genetic variants may double risk for Alzheimer's disease

NIH deposits first batch of genomic data for Alzheimer's disease

NIH-supported study identifies 11 new Alzheimer's disease risk genes

NIH funding boosts new Alzheimer's research on prevention, novel drug targets

Amylin deposits in the brain may link dementia and diabetes

Falls may be sign of future Alzheimer's disease, cognitive decline

Novel NIH initiative enables testing of existing compound as Alzheimer's treatment

Biomarkers can predict risk for Alzheimer's several years before symptoms appear

Suppressing protein may stem Alzheimer's disease process

Gene variant linked to higher risk of Alzheimer's in African Americans

NIH-supported study finds U.S. dementia care costs as high as $215 billion in 2010

Analysis finds gene variants associated with Alzheimer's amyloid deposition

NIH-supported Alzheimer's studies to focus on innovative treatments

NIH-supported international teams identify rare Alzheimer's disease risk gene variant

Genetic variation linked to age-related hearing loss

New database aims to capture international Alzheimer's disease research efforts

Risk gene for Alzheimer's disease associated with lower brain amyloid

Investigators create “brain map” of key epigenetic processes

CADRO: Common Alzheimer's Disease Research Ontology

Cancer drug bexarotene reverses Alzheimer's deficits in mice

Protein involved in brain-wave maintenance linked to Alzheimer's-related cognitive dysfunction

Alzheimer's Disease Research Summit offers research recommendations

NIH-funded research provides new clues on how ApoE4 affects Alzheimer's risk

Obama administration presents national plan to fight Alzheimer's disease

Alzheimer's Research Summit, May 14-15, 2012